Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Nunn

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Bulletin of the World Health Organization|February 7, 2003
How human immunodeficiency virus voluntary testing can contribute to tuberculosis controlPeter Godfrey-Faussett, Dermot Maher, Ya Diul Mukadi, et al.
IAPAC Monthly|May 15, 2003
How human immunodeficiency virus voluntary testing can contribute to tuberculosis controlPeter Godfrey-Faussett, Dermot Maher, Ya Diul Mukadi, et al.
Scandinavian Journal of Infectious Diseases|November 4, 2008
HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, UkraineIgor Raykhert, Kestutis Miskinis, Svitlana Lepshyna, et al.
The New England Journal of Medicine|September 10, 2010
MDR tuberculosis--critical steps for prevention and controlEva Nathanson, Paul Nunn, Mukund Uplekar, et al.
Lancet (London, England)|May 22, 2010
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisNeel R Gandhi, Paul Nunn, Keertan Dheda, et al.
The Journal of Infectious Diseases|July 18, 2006
Global incidence of multidrug-resistant tuberculosisMatteo Zignol, Mehran S Hosseini, Abigail Wright, et al.
BMJ Open|January 4, 2014
Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studiesThomas J Hwang, Svetlana Dotsenko, Azizkhon Jafarov, et al.
Emerging Infectious Diseases|October 25, 2012
Challenges and controversies in defining totally drug-resistant tuberculosisPeter Cegielski, Paul Nunn, Ekaterina V Kurbatova, et al.
Lancet (London, England)|December 19, 2006
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisMohamed Abdel Aziz, Abigail Wright, Adalbert Laszlo, et al.
The Lancet. Infectious Diseases|July 28, 2006
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaborationAlasdair Reid, Fabio Scano, Haileyesus Getahun, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Bulletin of the World Health Organization|February 7, 2003
How human immunodeficiency virus voluntary testing can contribute to tuberculosis controlPeter Godfrey-Faussett, Dermot Maher, Ya Diul Mukadi, et al.
IAPAC Monthly|May 15, 2003
How human immunodeficiency virus voluntary testing can contribute to tuberculosis controlPeter Godfrey-Faussett, Dermot Maher, Ya Diul Mukadi, et al.
Scandinavian Journal of Infectious Diseases|November 4, 2008
HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, UkraineIgor Raykhert, Kestutis Miskinis, Svitlana Lepshyna, et al.
The New England Journal of Medicine|September 10, 2010
MDR tuberculosis--critical steps for prevention and controlEva Nathanson, Paul Nunn, Mukund Uplekar, et al.
Lancet (London, England)|May 22, 2010
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosisNeel R Gandhi, Paul Nunn, Keertan Dheda, et al.
The Journal of Infectious Diseases|July 18, 2006
Global incidence of multidrug-resistant tuberculosisMatteo Zignol, Mehran S Hosseini, Abigail Wright, et al.
BMJ Open|January 4, 2014
Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studiesThomas J Hwang, Svetlana Dotsenko, Azizkhon Jafarov, et al.
Emerging Infectious Diseases|October 25, 2012
Challenges and controversies in defining totally drug-resistant tuberculosisPeter Cegielski, Paul Nunn, Ekaterina V Kurbatova, et al.
Lancet (London, England)|December 19, 2006
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisMohamed Abdel Aziz, Abigail Wright, Adalbert Laszlo, et al.
The Lancet. Infectious Diseases|July 28, 2006
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaborationAlasdair Reid, Fabio Scano, Haileyesus Getahun, et al.
Pageof 4